Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.

García-Monzón C, Lo Iacono O, Crespo J, Romero-Gómez M, García-Samaniego J, Fernández-Bermejo M, Domínguez-Díez A, Rodríguez de Cía J, Sáez A, Porrero JL, Vargas-Castrillón J, Chávez-Jiménez E, Soto-Fernández S, Díaz A, Gallego-Durán R, Madejón A, Miquilena-Colina ME.

Eur J Clin Invest. 2014 Jan;44(1):65-73. doi: 10.1111/eci.12192. Epub 2013 Nov 23.

PMID:
24134687
2.

High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C.

Petta S, Handberg A, Marchesini G, Cammà C, Di Marco V, Cabibi D, Macaluso FS, Craxì A.

J Viral Hepat. 2013 Mar;20(3):174-82. doi: 10.1111/j.1365-2893.2012.01641.x. Epub 2012 Jul 9.

PMID:
23383656
3.

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.

Miquilena-Colina ME, Lima-Cabello E, Sánchez-Campos S, García-Mediavilla MV, Fernández-Bermejo M, Lozano-Rodríguez T, Vargas-Castrillón J, Buqué X, Ochoa B, Aspichueta P, González-Gallego J, García-Monzón C.

Gut. 2011 Oct;60(10):1394-402. doi: 10.1136/gut.2010.222844. Epub 2011 Jan 26.

PMID:
21270117
4.

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.

Petta S, Cammà C, Di Marco V, Alessi N, Barbaria F, Cabibi D, Caldarella R, Ciminnisi S, Licata A, Massenti MF, Mazzola A, Tarantino G, Marchesini G, Craxì A.

Hepatology. 2008 Jul;48(1):28-37. doi: 10.1002/hep.22316.

PMID:
18506842
5.

Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.

Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2422-5.

PMID:
10522010
6.

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.

Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.

Hepatology. 2006 Dec;44(6):1648-55.

PMID:
17133473
7.

Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population.

Handberg A, Højlund K, Gastaldelli A, Flyvbjerg A, Dekker JM, Petrie J, Piatti P, Beck-Nielsen H; RISC Investigators.

J Intern Med. 2012 Mar;271(3):294-304. doi: 10.1111/j.1365-2796.2011.02442.x. Epub 2011 Sep 14.

8.

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.

Svegliati-Baroni G, Bugianesi E, Bouserhal T, Marini F, Ridolfi F, Tarsetti F, Ancarani F, Petrelli E, Peruzzi E, Lo Cascio M, Rizzetto M, Marchesini G, Benedetti A.

Gut. 2007 Sep;56(9):1296-301. Epub 2007 Mar 28.

9.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
10.

Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.

Argentou M, Tiniakos DG, Karanikolas M, Melachrinou M, Makri MG, Kittas C, Kalfarentzos F.

Obes Surg. 2009 Sep;19(9):1313-23. doi: 10.1007/s11695-009-9912-9. Epub 2009 Jul 15.

PMID:
19693638
11.

[Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].

Kim KO, Park SH, Park CH, Han TH, Yoo KS, Kim JH, Lee MS, Kim DJ, Park CK, Cho HD.

Korean J Hepatol. 2005 Mar;11(1):51-8. Korean.

12.

Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.

Kukla M, Berdowska A, Stygar D, Gabriel A, Mazur W, Łogiewa-Bazger B, Sobala-Szczygieł B, Bułdak RJ, Rokitka M, Zajęcki W, Kępa L, Sawczyn T, Zwirska-Korczala K.

Scand J Gastroenterol. 2012 Sep;47(8-9):1037-47. doi: 10.3109/00365521.2012.694901. Epub 2012 Jun 7.

PMID:
22670657
13.

Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.

Giannini E, Ceppa P, Botta F, Mastracci L, Romagnoli P, Comino I, Pasini A, Risso D, Lantieri PB, Icardi G, Barreca T, Testa R.

Am J Gastroenterol. 2000 Nov;95(11):3211-7.

PMID:
11095344
14.

The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.

Alkhouri N, Tamimi TA, Yerian L, Lopez R, Zein NN, Feldstein AE.

Dig Dis Sci. 2010 Sep;55(9):2644-50. doi: 10.1007/s10620-009-1075-y. Epub 2009 Dec 5.

PMID:
19960252
15.

Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.

Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.

Am J Gastroenterol. 2003 Sep;98(9):2064-71.

PMID:
14499789
16.

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.

Chan WK, Nik Mustapha NR, Mahadeva S.

J Gastroenterol Hepatol. 2014;29(7):1470-6. doi: 10.1111/jgh.12557.

PMID:
24548002
17.

A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.

Aigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A, Solioz M, Tilg H, Patsch W, Weiss G, Stickel F, Datz C.

Am J Gastroenterol. 2010 Sep;105(9):1978-85. doi: 10.1038/ajg.2010.170. Epub 2010 Apr 20.

PMID:
20407430
18.

Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.

Rodríguez-Hernández H, Gonzalez JL, Márquez-Ramirez MD, Flores-Hernandez M, Rodríguez-Morán M, Guerrero-Romero F.

Eur J Gastroenterol Hepatol. 2008 May;20(5):399-403. doi: 10.1097/MEG.0b013e3282f448af.

PMID:
18403941
19.

Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis.

Lonardo A, Ballestri S, Adinolfi LE, Violi E, Carulli L, Lombardini S, Scaglioni F, Ricchi M, Ruggiero G, Loria P.

Can J Gastroenterol. 2009 Apr;23(4):273-8.

20.

Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M.

J Hepatol. 2011 Jan;54(1):64-71. doi: 10.1016/j.jhep.2010.06.022. Epub 2010 Aug 21.

PMID:
20932598

Supplemental Content

Support Center